Conclusion
and Personal Note
“Truth
is a precious thing and should be used sparingly.”—Mark Twain
I
have squandered a good deal of this precious commodity in writing
this material—my supply is low—and it is time to conclude. With the
completion of A Remarkable Medicine Has Been Overlooked, I
will have done what I can to communicate the facts about PHT. The
Dreyfus Medical Foundation is going out of the communications business.
It is not that we have lost interest, but to continue to argue the
case for PHT would be counterproductive. This is a matter for others
now.
Duplicates
of the Foundation’s extensive files on PHT are herewith offered to
the federal government. Access to these files will continue to stay
in the field of PHT and hopes, selectively, to sponsor research in
new areas. Thank you if you have read some of this material. And the
best of everything to you. As for me, I am going to get in a rowboat
and float upstream.
Foundation Changes
In
1976, with mutual understanding our scientific Director, Dr. Samuel
Bogoch retired and returned to his personal interests in the field
of scientific research. I thanked him for his fine assistance and
his invaluable help with our bibliographies. And I thank him again.
An ever-increasing amount of medical studies were being published
around the world. Our excellent librarian, Vivian McDermott, and her
assistants continued to collect this literature. Soon it was obvious
that another bibliography was necessary.
In
1984, Dr. Barry Smith, an outstanding neurosurgeon, joined the Foundation
as Scientific Director. The PHT story appealed to Barry’s heart and
he’s been an extremely hard worker. With his help a third bibliography,
The Broad Range of Clinical Use of Phenytoin, was written—3,100
medical references. It was sent to all the physicians in the U.S.
(508,000), along with A Remarkable Medicine Has Been Overlooked.
Something Personal
I’ll
conclude with something personal. My life has been incredibly lucky
or, as suggested by the Reporting Angel, interfered with from above.
I’ve had the fortune to have many happy avocations: golf, tennis,
bridge, gin rummy, horse handicapping, race horses, and management
in the field of racing. In business there has been advertising and
marketing, Wall Street research, and making a great amount of money.
And then something far more important happened. I got out of a depression,
by finding that a great drug had been overlooked. This gave me a unique
privilege—to spend my money, and the last thirty-five years of my
life, trying to get the information to the rest of humanity. I can’t
imagine a nicer life. I thank God for it.